Collagen peptide is a natural body protein inside the body. It is produced in the body to prevent dermal layers of the skin from developing skin folds. Collagen peptide is made from collagen through an enzymatic hydrolysis process and which is why it is often referred to as hydrolyzed collagen. Collagen peptides are rich source of protein and healthy nutrition. They improve health of bones, and are effective for beautiful skin. Collagen peptide is used as cosmetic or medical collagen in different skin creams and treatments to reduce the appearance of wrinkles and to moisturize skin. The value of collagen peptide market is projected to grow with a CAGR between 7.0% and 8.0% during forecast period of 2016-2022 and reach USD XXX billion by 2022.
Increasing consciousness about wellbeing and wrinkle free skin in old-age and increasing awareness pertaining to the benefits of collagen peptide products about personal healthcare are expected to be the key driving growth factors. Further, increasing R&D activities for the development of novel drug formulations and favorable regulations for regenerative medicine application are anticipated to bring more opportunities for the major players in the market.
The report segments the collagen peptide market by source and application. Market segmentation based on source includes bovine, porcine, chicken, fish and other sources of collagen peptide. Moreover, based on application the collagen peptide market is segmented into bone and joint health, pharmaceuticals, cosmetics, nutraceuticals, food and beverages and pet food.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). Europe is the major producer of collagen products and is accounted as the largest share growth region for the collagen peptide market with a market share of more than 50% for being the major supplier of collagen ingredients to Asian market. Following Europe, North America is establishing its dominance over the market due to increase in awareness in healthcare and increasing R&D activities for novel drug delivery. While, Asia pacific is anticipated to grow at the highest CAGR over the forecast period and provide the opportunity for market growth due to rising awareness in healthcare and steadily increasing industrial sectors.
The companies covered in the report include
Bocell Technology LLC
Chinatech Peptides Co. Ltd
Interheath Nutraceuticals Inc
Weishardt International Group